Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details)

v3.21.2
Stockholders' Equity (Details) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Jul. 13, 2021
Jul. 06, 2021
May 06, 2021
Jan. 04, 2021
Jan. 19, 2021
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Nov. 11, 2021
Aug. 13, 2021
Stockholders' Equity (Textual)                      
Stock based compensation               $ 156,000      
Stock option (in Shares) 200,000   160,000                
Shares vest in equal annual installments 4 years   4 years                
Exercise price (in Dollars per share) $ 2.21   $ 2.48                
Aggregate grant date fair value $ 202,910   $ 145,777                
Purchase of an aggregate shares (in Shares)               340,000      
Purchase of common shares (in Shares)               187,500      
Stock-based compensation expense           $ 151,220 $ 508,268 $ 1,081,362 $ 4,729,643    
Restricted shares of common stock (in Shares)               11,521      
Stock based compensation included in discontinued operation               $ 15,466      
Restricted stock unit agreement, description   On July 6, 2021, the Board approved the following compensation for non-executive directors: (i) annual $30,000 fee for director services; (ii) annual $10,000 fee for non-chair committee services (capped at $10,000 per director); and (iii) annual $15,000 fee for committee chairs (capped at $15,000 per director).                  
Pay of award cash               $ 1,000,000      
Plan [Member]                      
Stockholders' Equity (Textual)                      
Number of shares of common stock available (in Shares)           233,444   233,444   3,763,305  
Stock Options [Member]                      
Stockholders' Equity (Textual)                      
Stock-based compensation expense           $ 613,070 312,117 $ 1,122,767 766,279    
Net income of discontinued operations           633,197 55,063 746,410 156,695    
Unrecognized compensation expense           1,191,826   $ 1,191,826      
Weighted average remaining vesting period               2 years 6 months 21 days      
Restricted Stock [Member]                      
Stockholders' Equity (Textual)                      
Stock-based compensation expense           58,923 265,050 $ 219,853 496,361    
Net income of discontinued operations           (12,425) $ 13,836 14,848 $ 26,302    
Unrecognized compensation expense           140,274   $ 140,274      
Weighted average remaining vesting period               10 months 24 days      
Restricted Stock Units (RSUs) [Member]                      
Stockholders' Equity (Textual)                      
Stock-based compensation expense           $ 100,000   $ 300,000      
Restricted stock unit agreement, description         pursuant to which the CEO received restricted stock units having a stated value equal to $1,000,000. The restricted stock units represent the right to receive $1,000,000, contingent upon the closing of the Sale Transaction, which is payable upon the earlier of the two-year anniversary of the closing date of the Sale Transaction (provided that the CEO remains continuously employed by the Company through such date), or the termination of the CEO’s employment without cause after the closing of the Sale Transaction (as defined in his employment agreement) (as applicable, the “Vesting Date”).            
2019 Equity Incentive Plan [Member] | Minimum [Member]                      
Stockholders' Equity (Textual)                      
Common stock authorized (in Shares)                     3,463,305
2019 Equity Incentive Plan [Member] | Maximum [Member]                      
Stockholders' Equity (Textual)                      
Common stock authorized (in Shares)                     7,800,000
Equity Incentive Plan [Member]                      
Stockholders' Equity (Textual)                      
Aggregate shares of common stock (in Shares)       126,584              
Stock based compensation       $ 200,000